Clinical Trial Update: Epidemiology of MDR-TB in Peru

View source ↗

Summary

An update on the epidemiology of multidrug-resistant tuberculosis in Peru from the NCT00676754 trial led by Harvard researchers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: Harvard University Faculty of Medicine | Conditions: TB Multi-drug Resistant | Status: UNKNOWN